Vertex Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Other corporations in the scoring peer group for Vertex Pharmaceuticals Inc are displayed. If you are employed by Vertex Pharmaceuticals Inc and you would like to licence your Sustainability aseessment, please get in touch. This dashboard includes a Q&A table about Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.2; made up of an environmental score of 3.0, social score of 5.0 and governance score of 4.6.
4.2
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
951 | Purple Biotech Ltd | 4.3 | High |
951 | Vectura Group Services Ltd | 4.3 | High |
969 | Vertex Pharmaceuticals Inc | 4.2 | High |
969 | Botanix Pharmaceuticals Ltd | 4.2 | High |
969 | Arvinas Inc | 4.2 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Vertex Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does Vertex Pharmaceuticals Inc disclose current and historical energy intensity?
Does Vertex Pharmaceuticals Inc report the average age of the workforce?
Does Vertex Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does Vertex Pharmaceuticals Inc disclose its ethnicity pay gap?
Does Vertex Pharmaceuticals Inc disclose cybersecurity risks?
Does Vertex Pharmaceuticals Inc offer flexible work?
Does Vertex Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Vertex Pharmaceuticals Inc disclose the number of employees in R&D functions?
Does Vertex Pharmaceuticals Inc conduct supply chain audits?
Does Vertex Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Vertex Pharmaceuticals Inc conduct 360 degree staff reviews?
Does Vertex Pharmaceuticals Inc disclose the individual responsible for D&I?
Does Vertex Pharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Vertex Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does Vertex Pharmaceuticals Inc disclose water use targets?
Does Vertex Pharmaceuticals Inc have careers partnerships with academic institutions?
Did Vertex Pharmaceuticals Inc have a product recall in the last two years?
Does Vertex Pharmaceuticals Inc disclose incidents of discrimination?
Does Vertex Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has Vertex Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does Vertex Pharmaceuticals Inc disclose parental leave metrics?
Does Vertex Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does Vertex Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Vertex Pharmaceuticals Inc disclose the pay ratio of women to men?
Does Vertex Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does Vertex Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Vertex Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Vertex Pharmaceuticals Inc involved in embryonic stem cell research?
Does Vertex Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does Vertex Pharmaceuticals Inc disclose its waste policy?
Does Vertex Pharmaceuticals Inc report according to TCFD requirements?
Does Vertex Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Vertex Pharmaceuticals Inc disclose energy use targets?
Does Vertex Pharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Vertex Pharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Vertex Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.